Integrated Filing — IndAS



General information about company

Scrip Code 543275
NSE Symbol ANURAS
MSEI Symbol NOTLISTED
ISIN INE930P01018
Name of company ANUPAM RASAYAN INDIA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 23-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 20-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Manufacturing of Industrial Chemicals
Start date and time of board meeting 23-05-2026   12:45:00
End date and time of board meeting 23-05-2026   16:55:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 10-03-2025
Indicate Company website link for updated RPT policy of the Company https://www.anupamrasayan.com/investors/policies-practices/policy-on-related-party-transactions-and-material-subsidiaries
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 37,057.90 1,67,556.70
Other income 248.60 1,996.40
Total income 37,306.50 1,69,553.10
2 Expenses
(a) Cost of materials consumed 19,921.70 1,02,432.90
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (2,290.40) (8,423.70)
(d) Employee benefit expense 1,124.20 4,507.50
(e) Finance costs 3,737.00 13,943.50
(f) Depreciation, depletion and amortisation expense 3,142.30 11,479.90
(f) Other Expenses
1 Other Expenses 8,204.20 28,520.10
Total other expenses 8,204.20 28,520.10
Total expenses 33,839.00 1,52,460.20
3 Total profit before exceptional items and tax 3,467.50 17,092.90
4 Exceptional items 0.00 0.00
5 Total profit before tax 3,467.50 17,092.90
6 Tax expense
7 Current tax 601.70 2,986.20
8 Deferred tax (1,372.60) (2,032.90)
9 Total tax expenses (770.90) 953.30
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 4,238.40 16,139.60
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 4,238.40 16,139.60
17 Other comprehensive income net of taxes 61.80 (55.70)
18 Total Comprehensive Income for the period 4,300.20 16,083.90
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 11,384.80 11,384.80
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 3,12,110.40
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.73 14.32
Diluted earnings (loss) per share from continuing operations 3.73 14.32
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.73 14.32
Diluted earnings (loss) per share from continuing and discontinued operations 3.73 14.32
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1.The above Standalone financial results for the quarter and year ended March 31 2026 have been prepared by the Company in accordance with Regulation 33 of SEBI Listing Obligations and Disclosure Requirements Regulations 2015 as amended and were reviewed by the Audit Committee of the Board and thereafter were approved and taken on record by the Board of Directors in their meeting held on May 23 2026. 2.Based on the management approach as defined in Ind AS 108 Operating Segments the Chief Operating Decision Maker CODM evaluates the companys performance and allocates resources based on an analysis of various performance indicators of business segments in which the company operates. The Company is primarily engaged in the business of custom synthesis and manufacturing of specialty chemicals which the management and CODM recognise as the sole business segment. Hence disclosure of segment wise information is not required and accordingly not provided. 3.The company consummated acquisition of 100 percent equity stake in Jayhawk Fine Chemicals Corporation Jayhawk part of the CABB group a U.S. based specialty chemical company for a purchase consideration of US dollar150 million through its wholly owned subsidiary Doriath S.a r.l. Detail disclosure in this regard has been made via press release dated February 27 2026 submitted with the stock exchanges vide Document No. ARILSLDSTX20260227093. 4.The Group has recognised the goodwill of INR 5402.56 million related to the acquisition of JayHawk Fine Chemicals Corporation a U.S based specialty chemical company through its wholly owned subsidiary Doriath S.a.r.l on a provisional basis as per Ind AS 103 Business Combinations since the valuation of certain identifiable intangible assets property plant and equipment and related deferred taxes is under process with the valuers. The Group expects to finalize the purchase price allocation within the measurement period permitted under Ind AS 103. 5.The Board of Directors have recommended final dividend of INR 1.5 at 15 percent per Equity Share of face value of INR 10 each for the financial year 2025 to 2026. 6.Deferred tax assets and liabilities have been recomputed based on the enactment of Finance Bill 2026. The resulting impact of the remeasurement of deferred tax balances has been recognized in the Statement of Profit and Loss for the year. 7.The figures for the quarter ended March 31 2026 and March 31 2025 are the balancing figures between audited figures in respect of the full financial year and the published year to date figures up to Nine months of the relevant financial year which were subjected to limited review. 8.The figures of the previous period have been regrouped rearranged and or recasted wherever considered necessary.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 2,16,328.60
Capital work-in-progress 6,843.90
Investment property
Goodwill 0.00
Other intangible assets 2,320.40
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 35,013.00
Trade receivables, non-current
Loans, non-current 1,462.90
Other non-current financial assets
1 Other financial assets 18,391.70
Total of other non-current financial assets 18,391.70
Total non-current financial assets 54,867.60
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 27,818.10
Total of other non-current assets 27,818.10
Total non-current assets 3,08,178.60
2 Current assets
Inventories 1,39,802.00
Current financial asset
Current investments 0.00
Trade receivables, current 91,995.90
Cash and cash equivalents 5,617.40
Bank balance other than cash and cash equivalents 737.70
Loans, current 164.30
Other current financial assets
Total of other current financial assets 101.30
Total current financial assets 98,616.60
Current tax assets (net) 0.00
Other current assets
1 Other current assets 43,160.90
Total of other current assets 43,160.90
Total current assets 2,81,579.50
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 5,89,758.10
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 11,384.80
Other equity 3,12,110.40
Total equity attributable to owners of parent 3,23,495.20
Non controlling interest
Total equity 3,23,495.20
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 31,732.50
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease Liability 4,647.90
2 Other financial liabilities 3,439.70
Total of other non-current financial liabilities 8,087.60
Total non-current financial liabilities 39,820.10
Provisions, non-current 0.00
Deferred tax liabilities (net) 8,653.90
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 48,474.00
Current liabilities
Current financial liabilities
Borrowings, current 1,20,573.20
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 111.40
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 86,210.70
Total Trade payable 86,322.10
Other current financial liabilities
1 Lease Liability 426.20
2 Other financial liabilities 7,068.10
Total of other current financial liabilities 7,494.30
Total current financial liabilities 2,14,389.60
Other current liabilities 705.60
1 Other current liabilities 705.60
Total of other current liabilities 705.60
Provisions, current 2,130.60
Current tax liabilities (Net) 563.10
Deferred government grants, Current
Total current liabilities 2,17,788.90
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 2,66,262.90
Total equity and liabilites 5,89,758.10
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Gain/(loss) on remeasurements of the defined benefits plan 95.00 (85.50)
2 Income tax (expense)/income on remeasurements of defined benefits plan (33.20) 29.80
Total Amount of items that will not be reclassified to profit and loss 61.80 (55.70)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of gain/(loss) on hedging instruments in a cash flow hedge 0.00 0.00
2 Income tax (expense)/income on effective portion of gain/(loss) on hedging instruments in a cash flow hedge 0.00 0.00
Total Amount of items that will be reclassified to profit and loss 0.00 0.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 61.80 (55.70)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 17,092.90
Adjustments for reconcile profit (loss)
Adjustments for finance costs 13,943.50
Adjustments for decrease (increase) in inventories (4,341.40)
Adjustments for decrease (increase) in trade receivables, current (44,408.40)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 235.30
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 36,476.20
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 11,479.90
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 5.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (507.00)
Adjustments for dividend income 231.60
Adjustments for interest income 0.00
Adjustments for share-based payments 2.80
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (134.00)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 88.10
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 12,608.40
Net cash flows from (used in) operations 29,701.30
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 2,284.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 27,417.30
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 80.50
Purchase of property, plant and equipment 44,380.60
Proceeds from sales of investment property 0.00
Purchase of investment property 19,066.10
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 257.80
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 231.60
Interest received 0.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (2,192.40)
Net cash flows from (used in) investing activities (65,584.80)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 27,754.70
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 24,059.80
Repayments of borrowings 0.00
Payments of lease liabilities 2,874.60
Dividends paid 853.80
Interest paid 12,482.40
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 35,603.70
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (2,563.80)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (2,563.80)
Cash and cash equivalents cash flow statement at beginning of period 8,181.20
Cash and cash equivalents cash flow statement at end of period 5,617.40





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s. Natvarlal Vepari & Co. Yes 31-05-2027


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Anupam Rasayan India Limited Anand Desai Managing Director Remuneration Remuneration of Managing Director is duly recommended by the Nomination and Remuneration Committee and approved by the Board of Directors and Shareholders of the Company 250.00 25.00 24.50
2 Anupam Rasayan India Limited Mona Desai Whole-time Director Remuneration Remuneration of Whole-time Director is duly recommended by the Nomination and Remuneration Committee and approved by the Board of Directors and Shareholders of the Company 250.00 25.00 24.50
3 Anupam Rasayan India Limited Tangent Science Private Limited Associate of Subsidary Company Sale of goods or services 3,001.00 Omnibus Approval granted by the Audit Committee 1,247.00 878.20 2,185.90
4 Anupam Rasayan India Limited Tangent Science Private Limited Associate of Subsidary Company Purchase of goods or services 4,490.00 Omnibus Approval granted by the Audit Committee 322.20 (987.70) 0.00
5 Anupam Rasayan India Limited Tangent Science Private Limited Associate of Subsidary Company Advance 7,500.00 Audit Committee has approved the matter 0.00 7,472.80 7,472.80 Advance 0 72 Months Unsecured Supply of Material Textual Information(1)
6 Anupam Rasayan India Limited Tangent Science Private Limited Associate of Subsidary Company Any other transaction Sale of Land 837.20 Audit Committee has approved the matter 0.00 837.20 837.20
7 Anupam Rasayan India Limited Tangent Science Private Limited Associate of Subsidary Company Any other transaction Sale of capital goods/engineering equipments 250.00 Audit Committee has approved the matter 32.50 0.00 0.00
8 Anupam Rasayan India Limited Tanfac Industries Limited Subsidiary company over which a holding company exercises effective control Purchase of goods or services 4,776.00 Omnibus Approval granted by the Audit Committee 205.20 2,135.50 1,322.20
9 Anupam Rasayan India Limited ARIL Transmodal Logistic Private Limited Wholly-owned Subsidary Any other transaction Service availed 840.00 Audit Committee has approved the matter 226.90 (78.20) 0.00
10 Anupam Rasayan India Limited ARIL Fluorospeciality Private Limited Wholly-owned Subsidary Loan 4,000.00 Audit Committee has approved the matter 35.90 3,848.30 3,884.30 Loan 9.00 10 Years Unsecured Principal Buisness Activites
11 Anupam Rasayan India Limited ARIL Fluorospeciality Private Limited Wholly-owned Subsidary Interest received Audit Committee has approved the matter 173.80 582.40 738.80 Loan 9.00 10 Years Unsecured Principal Buisness Activites
12 Anupam Rasayan India Limited Jainam Intermediates Private Limited Wholly-owned Subsidary Purchase of goods or services 3,400.00 Omnibus Approval granted by the Audit Committee 1,007.50 (386.80) 0.00
13 Anupam Rasayan India Limited Anupam Japan GK Wholly-owned Subsidary Any other transaction Advance 50.00 Audit Committee has approved the matter (7.80) 7.80 0.00
14 Anupam Rasayan India Limited Anupam Europe AG Wholly-owned Subsidary Sale of goods or services 3,500.00 Omnibus Approval granted by the Audit Committee 390.70 585.30 195.70
15 Anupam Rasayan India Limited Anupam Europe AG Wholly-owned Subsidary Loan 236.80 Audit Committee has approved the matter 233.80 0.00 233.80
16 Anupam Rasayan India Limited Anupam Europe AG Wholly-owned Subsidary Interest received Audit Committee has approved the matter 0.60 0.00 0.60
17 Anupam Rasayan India Limited Anupam General Trading FZE Wholly-owned Subsidary Sale of goods or services 8,500.00 Omnibus Approval granted by the Audit Committee 6,578.10 1,877.80 1,865.10
18 Anupam Rasayan India Limited Anupam General Trading FZE Wholly-owned Subsidary Investment 200.00 Audit Committee has approved the matter 199.10 0.00 0.00
19 Anupam Rasayan India Limited Anupam General Trading FZE Wholly-owned Subsidary Loan 23.70 Audit Committee has approved the matter 23.40 0.00 23.40 Loan 8.500 10 Unsecured Principal Buisness Activites
20 Anupam Rasayan India Limited Anupam General Trading FZE Wholly-owned Subsidary Interest received Audit Committee has approved the matter 0.10 0.00 0.10 Loan 8.500 10 Unsecured Principal Buisness Activites
21 Anupam Rasayan India Limited Anupam USA LLC Wholly-owned Subsidary Sale of goods or services 40,000.00 Omnibus Approval granted by the Audit Committee 0.00 34,514.60 14,025.60
22 Anupam Rasayan India Limited Doriath S.a.r.l Wholly-owned Subsidary Investment Audit Committee has approved the matter 19,065.10 0.00 0.00
Total value of transaction during the reporting period 30,234.10



Text Block

Textual Information(1) Approval of the audit commitee for non-interest bearing security deposit amounting to 750 million towards the performance of contract for purchase of raw material from Tangent Science Private Limited